SUMMARY Twenty-five non-demented patients with mild, idiopathic, Parkinson's disease were compared with 25 age and education matched normal controls on a visuo-spatial performance task, whose characteristics were directional forecast, with minimal motor requirement and a maximal spatial load. No statistical support was found for the existence of spatial impairment in these patients.
It is still debated whether dementia should be considered as a regular feature of Parkinson's disease or as limited to a subgroup of patients. There is, however, much evidence to suggest that dementia is likely to be related in some way to Parkinson's disease. 1'-Quoted prevalence figures for dementia in Parkinson's disease range from as low as 2%6 based on clinical notes, to 93%3 on psychometric evaluations, the higher percentages being reported in recent years. A convincing interpretation has not yet been given of these differences.
Amongst the cognitive impairments reported in Parkinsonians, visuo-spatial deficits are claimed to be the most frequent.7-32 Indeed, they are also maintained to be "unique, specific, and independent" from more widespread dementia. '4 21 26 33 34 This finding also gains support from behavioural results of experimental lesions located in the basal ganglia of mammals, 12 35 42 from subcortical stimulation studies43 44 and from the cognitive impairment produced by surgical lesions of basal ganglia in human beings. Both experimental and neurosurgical lesions, as well as stimulation studies, however, are not limited to the nigro-striatal pathways. Finally it is worth mentioning that visual abnormalities have been found in Parkinson's disease, the occurrence of which does not seem to be due to motor impairment.48-5-A few studies, however, have failed to find visuo-spatial differences between Parkinsonians and normal controls.26 51 5 This inconsistency may be due to differences in patient-control selection criteria, in severity, length and age of onset of the disease, in the difficulty of the task and in its motor requirements, in the presence of time-constraints in the task (a variable which obviously penalises bradykinetic Parkinsonians), in the contribution of depression in medical and surgical treatments, in the presence of other risk factors for cognitive impairment such as normal ageing, associated cerebrovascular disorders, Alzheimer-like or extra-nigral degenerative disorders.
Unfortunately there are few studies which take into account the majority of these sources of biases.52 53 58-60 To study the hypothesis that a bilateral degeneration limited to the nigral dopaminergic system causes a specific visuo-spatial impairment, we have studied a homogeneous sample of mildly disabled patients with idiopathic Parkinson's disease. All were levodopa responders, never exposed to anticholinergic drugs. None fig 2. Experiment 2 (that is, with the "rebound surface") was the more difficult task, giving rise to a greater overall inaccuracy. In both experiments the shortest (that is, 3 cm long) segment produced the poorest directional forecast (see also fig 3) .
The results of the 2 x 3 x 2 ANOVA for the inaccuracy scores, were as follows: whereas the second order interaction (that is, interaction between experimental groups, length of segments and experimental settings) clearly fell far below significance (F 1,48 = 2-162, p: NS), two out of three first order interactions achieved significance: (1) interaction between experimental groups and length of segments (F 2,96 = 3-470, p < 0-05) indicating that groups were sensitive to the length of the segments acting as visuo-spatial stimulus for directional forecast. One can infer that Parkinsonians were more sensitive than normal controls (that is, more inaccurate) to the shortest segment (that is, to the most difficult one). (see Fig 3) . (2) Summing up, Parkinsonians were as inaccurate in their directional forecast as normal controls. Actually the experimental groups acted as a non-significant source of variability (F 1,48 = 2-162, p: NS). There was, however, irrespective of the experimental setting, a tendency of Parkinsonians to be somewhat more sensitive than controls to the less informative stimulus (that is the shortest segment). To solve the ambiguity produced by the contrast of non-significant higher order interaction compared to lower level significant interactions (chiefly between experimental groups and length of the segments), we resorted a posteriori to two separate 3 x 2 ANOVAs: one for each experimental setting. In both conditions, the Parkinsonians vs normal controls difference turned out to be unequivocally non-significant (Experiment 1: F 2,96 = 2-703; Experiment 2: F 2,96 < 1), whereas, in both, segment length appeared to be a highly significant source of variability acting independently of experimental groups.
Three further analyses were undertaken to clarify marginal details of the performance of Parkinsonians: (1) the same statistical analysis was run on signed error scores, that is for each trial of each experimental subject, noting whether the error was committed left or right of the ideal interception point (see fig la and  b) . The outcome was only marginally different from that found previously: length of segments remained highly significant (F 2,96 = 24 453; p < 0 0001) as well as the interaction between segment length and experimental setting (F 2 ,96 = 13 355; p < 0 0001), whilst both the experimental setting and the interaction between groups and length of segments fell short of significance (respectively, F 1,48 = 1 097 and F 2,96). Both group difference and the second order interaction remained far below significance (respectively F 1,48 < 1 and F 2,96 < 1). Taking these findings together, they rule out a systematical directional trend in giving rise to the mean error scores set out in figs 2 and 3. Hence we are confident that the dependent variable employed in this study actually reflects an inaccuracy behaviour and not a directional trend in committing forecast errors.
(2) The role of length of illness, daily levodopa intake, overall severity (NUDS-scores) and motor impairment measured by means of the Screw Rota- Is there a specific visuo-spatial impairment in Parkinsonians? Hence part of the discrepancy between our results and those of most of the other authors could be linked to a test-bias, this is to say that mild Parkinsonians are insensitive to tests with a nearly exclusively spatial load, simply because they do not have any true spatial disorder. Both sample-biases and test-biases highlight the methodological problems in investigating cognitive impairments in Parkinsonians and making general inferences. A final point is that none of our Parkinsonians received anticholinergic treatment. It is a hypothesis with some experimental support71 -74 that anticholinergics are liable to interfere with cognition (but usually data refer to memory and not to strict spatial performances).
Though it is hazardous to draw conclusions from a set of statistically non-significant results in a highly selected sample of patients, we are strongly inclined to think that purely spatial impairments are not part of specific cognitive disorders in Parkinson's disease as long as its dopaminergic imbalance is confined to the nigro-striatal system. It could, however, be inferred that spatial impairment is the consequence of a widespread, possibly cortical, extra-nigral degenerative process, whose nature could be akin or even identical to that found in Alzheimer disease. 
